Unconventional viral gene expression mechanisms as therapeutic targets

Nature. 2021 May;593(7859):362-371. doi: 10.1038/s41586-021-03511-5. Epub 2021 May 19.

Abstract

Unlike the human genome that comprises mostly noncoding and regulatory sequences, viruses have evolved under the constraints of maintaining a small genome size while expanding the efficiency of their coding and regulatory sequences. As a result, viruses use strategies of transcription and translation in which one or more of the steps in the conventional gene-protein production line are altered. These alternative strategies of viral gene expression (also known as gene recoding) can be uniquely brought about by dedicated viral enzymes or by co-opting host factors (known as host dependencies). Targeting these unique enzymatic activities and host factors exposes vulnerabilities of a virus and provides a paradigm for the design of novel antiviral therapies. In this Review, we describe the types and mechanisms of unconventional gene and protein expression in viruses, and provide a perspective on how future basic mechanistic work could inform translational efforts that are aimed at viral eradication.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use*
  • Frameshifting, Ribosomal / drug effects
  • Frameshifting, Ribosomal / genetics
  • Gene Expression Regulation, Viral / drug effects*
  • Gene Expression Regulation, Viral / genetics
  • Genome, Viral / drug effects
  • Genome, Viral / genetics
  • Host Microbial Interactions / drug effects*
  • Host Microbial Interactions / genetics*
  • Humans
  • RNA Splicing / drug effects
  • RNA Splicing / genetics
  • Virus Diseases / drug therapy*
  • Virus Diseases / virology*

Substances

  • Antiviral Agents